Sri Ramaswami

Bio:

Sri Ramaswami is currently the Senior Vice President and Global Head of Corporate Affairs and Investor Relations at Galapagos N.V., a biotechnology company with operations in Europe, the U.S., and Asia, dedicated to transforming patient outcomes through life- changing science and innovation for more years of life and quality of life. With capabilities from lab to patient, including a decentralized cell therapy manufacturing platform, Galapagos is committed to challenging the status quo and delivering results for patients, employees, and shareholders. Prior to his appointment at Galapagos, Sri was Vice President and Head of U.S. Commercial Communications for GSK, based in Philadelphia. In this role, he led teams responsible for oncology, respiratory, specialty and vaccines communication, employee engagement, as well as partnerships and the NC GlaxoSmithKline Foundation. Sri was also a member of the GSK U.S. Country Executive Board, the U.S. Commercial leadership team, and the Chairman of the GSK U.S. Charitable Contributions Committee.

Before joining GSK, Sri was Vice President, Chief Communications Officer for Caris Life Sciences, focused on fulfilling the promise of precision medicine. Prior to Caris, Sri was Executive Vice President, Global and Emerging Markets, Healthcare at rbb Communications. In this role, he helped build the rbb healthcare brand and conducted groundbreaking work on healthcare through leadership, patient advocacy, and disease awareness. His passion to elevate humanity and help patients drove much of his work in this role. While at rbb, he formed a health advisory council and assembled an A team of strategic thinkers with track records for flawless execution.

Prior to his appointment at rbb, he was the global leader for stakeholder activation at Johnson & Johnson Medical Devices. During his twelve years at Johnson & Johnson, he held positions of increasing responsibility in Communication & Public Affairs across the Pharmaceuticals & Medical Device segments including head of neuroscience communication, head of R&D communication, and head of the pharmaceuticals business of Johnson & Johnson in China. Sri was also Vice President of corporate communications for the Asia-Pacific region of J&J based in Singapore. Throughout his pharmaceuticals career, Sri also held key communication positions at Pfizer, Inc. and Merck & Co., Inc.

A U.S. national, Sri has worked in global, local, and regional roles in the world's largest markets, including the U.S., Japan, China, and India. He holds a Doctorate in Jurisprudence from Buffalo Law School, an M.S. in Journalism from Columbia University, and a

B.A. in politics and economics with a minor in Philosophy from Brandeis University.